Mr. Jeffrey Sherman reports

TELESCOPE INNOVATIONS PRESENTS RESULTS OF FIRST FISCAL QUARTER 2024

Telescope Innovations Corp. has released financial results for the fiscal quarter ended Nov. 30, 2023. The company generated revenues of $1.5-million for a net income of $215,000.

Financial highlights of the fiscal quarter ended Nov. 30, 2023:

• Revenues of $1,504,852, representing 300-per-cent growth over Q1 2023;
• Expenses of $1,289,852;
• Net income of $215,000.

"Our strong performance this quarter has been driven by the increasing momentum of our flagship product, DirectInject-LC," commented Jeffrey Sherman, chief operating officer of Telescope. "We have also continued to expand our technology and process development services with strategic partners in the pharmaceutical and chemical manufacturing sectors. Our automation and advanced analytical technology have been making big impacts in these industries by accelerating chemical process development, increasing data quality and reducing development costs."

Readers are encouraged to review the full financial statements and accompanying management discussion and analysis for the quarter ended Nov. 30, 2023, both of which are available under the profile for the company on SEDAR+.

About Telescope Innovations Corp.

Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.